UBS Group’s ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share ATIP.WS Stock Holding History

UBS Group's ATIP.WS Position: Q2 2023 in Review

UBS Group sold out of ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share (ATIP.WS) in Q2 2023, closing a stake of 725 shares — an estimated $19 sold.

UBS Group first reported a position in ATIP.WS in Q2 2021 and held it in 8 quarters. The position peaked at $27K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATIP.WS as of Q2 2023.

• UBS Group reported no remaining ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position as of Q2 2023 after selling out during the quarter.
• UBS Group sold 725 ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share shares in Q2 2023, an estimated $19.
• UBS Group first reported a position in ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share in Q2 2021 and held it in 8 quarters.
• UBS Group's ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share position peaked at $27K in Q2 2021.
• 1 fund tracked by Wall St. Rank held ATI Physical Therapy, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.